Cambridge Cancer Genomics (CCG) is a company that develops data-driven cancer treatment solutions. It builds software to enable data-driven precision oncology and designs data-driven biomarkers indicative of treatment response. CCG technology can detect relapse, predict response to therapy, and reduce ineffective treatment regimens.